Literature DB >> 14687720

Neurotransmitters regulate the migration and cytotoxicity in natural killer cells.

Kerstin Lang1, Theodore L Drell, Bernd Niggemann, Kurt S Zänker, Frank Entschladen.   

Abstract

Natural killer (NK) cells and cytotoxic T lymphocytes (CTL), the functional coordination of which are governed by various signal substances, are crucial in the body's defense of tumor and virus-infected cells. We investigated the role of various neurotransmitters and hormones on the regulation of functional parameters, including NK cell cytotoxicity, and the migration of NK cells and CTL within a three-dimensional collagen lattice. Using peripheral blood CTL and NK cells, we show that the neurotransmitters endorphin, histamine and substance P increase NK cell cytotoxicity, while norepinephrine inhibits cytotoxicity. Moreover, substance P reduces migratory activity, while norepinephrine increases NK cell and CTL migration. Furthermore, all three steroid hormones which were investigated, namely cortisone, testosterone, and estradiol, had regulatory influence on both cytotoxicity and migration of NK cells. These results further specify the functional basis of the complex interconnection between the immune and neuro-endocrine systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14687720     DOI: 10.1016/j.imlet.2003.09.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  25 in total

Review 1.  Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.

Authors:  Esther M Sternberg
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

Review 2.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 3.  Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.

Authors:  Jordan B Joiner; Yuliya Pylayeva-Gupta; Paul A Dayton
Journal:  J Immunol       Date:  2020-11-01       Impact factor: 5.422

Review 4.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

5.  Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition.

Authors:  Priscila O Barros; Thais B Ferreira; Morgana M M Vieira; Carla Renata M Almeida; Carlos Fernando Araújo-Lima; Renato G Silva-Filho; Joana Hygino; Regis M Andrade; Arnaldo F Andrade; Cleonice A Bento
Journal:  J Clin Immunol       Date:  2010-09-24       Impact factor: 8.317

Review 6.  A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency.

Authors:  Sherrie Divito; Thomas L Cherpes; Robert L Hendricks
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.

Authors:  Linda Monaco-Shawver; Lynnae Schwartz; Florin Tuluc; Chang-Jiang Guo; Jian Ping Lai; Satya M Gunnam; Laurie E Kilpatrick; Pinaki P Banerjee; Steven D Douglas; Jordan S Orange
Journal:  J Leukoc Biol       Date:  2010-10-12       Impact factor: 4.962

Review 8.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

Review 9.  Neurotransmitters: emerging targets in cancer.

Authors:  Shu-Heng Jiang; Li-Peng Hu; Xu Wang; Jun Li; Zhi-Gang Zhang
Journal:  Oncogene       Date:  2019-09-16       Impact factor: 9.867

10.  Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes.

Authors:  Carina Strell; Anne Sievers; Philipp Bastian; Kerstin Lang; Bernd Niggemann; Kurt S Zänker; Frank Entschladen
Journal:  BMC Immunol       Date:  2009-12-08       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.